An Alzheimer’s Drug Trial Gave Me Hope, and Then It Ended [The New York Times]
New York Times Company (The) (NYT)
Last new york times company (the) earnings: 2/6 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.nytco.com/investors/default.aspx
Company Research
Source: The New York Times
An Alzheimer’s Drug Trial Gave Me Hope, and Then It Ended - The New York Times I knew that participating in a clinical trial for an Alzheimer’s drug was unlikely to help me. But it gave me hope. So when the news broke this week It had been a difficult week already. The night before Biogen canceled the trial, I realized that I was losing 12 years of memories of my cherished dog This disease is bad. I feel as if I’m getting erased and medical doesn’t have any answers. My phone began to ring, followed by Facebook messages: “Did you see the news today?” Biogen and its research partner Eisai canceled the trial after an independent review of data determined that the drug was unlikely to help Alzheimer’s patients when compared to a placebo. “This disappointing news confirms the complexity of treating Alzheimer’s disease and the need to further advance knowledge in neuro,” Michel Vounatsos, Biogen’s chief executive, said in a statement I too am deeply disappointed but overwhelmingly grateful
Show less
Read more
Impact Snapshot
Event Time:
NYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYT alerts
High impacting New York Times Company (The) news events
Weekly update
A roundup of the hottest topics
NYT
News
- Who Is David Pecker? Ex-National Enquirer Publisher Tells Trump Jurors His Tabloid Would ‘Embellish' Stories In Trump's Favor [Forbes]Forbes
- NYU, Columbia, Yale Crack Down On Demonstrators As Anti-Israel Protests Intensify [zero hedge]zero hedge
- Did the Israel-Hamas War Influence Your Seder Rituals? Tell Us. [The New York Times]The New York Times
- Winner, Winner, Hot Honey Chicken Dinner [The New York Times]The New York Times
- 5 Fascinating Jobs That Are Perfect For Gamers [Forbes]Forbes
NYT
Earnings
- 2/7/24 - Beat
NYT
Sec Filings
- 4/22/24 - Form 4
- 4/22/24 - Form 4
- 4/22/24 - Form 4
- NYT's page on the SEC website